Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/mirxes-holding-company-limited" target="_blank" data-smartkarma-citation="entities:39971:1" rel="noopener">Mirxes Holding (2629 HK)</a> announced the placement of 21.9M shares for subscription at HK$32.5 per share.</li>
<li>Mirxes intends to use the proceeds majorly for investments, mergers &amp; acquisitions activities, research and development, expansion into emerging markets such as India and working capital purpose.  </li>
<li>Mirxes has established a strong competitive position in a niche category. Their comprehensive pipeline of early disease detection has significant market opportunities globally.</li>
</ul>



Mirxes Holding (2629 HK) announced the placement of 21.9M shares for subscription at HK$32.5 per share.
Mirxes intends to use the proceeds majorly for investments, mergers &amp; acquisitions activities, research and development, expansion into emerging markets such as India and working capital purpose.  
Mirxes has established a strong competitive position in a niche category. Their comprehensive pipeline of early disease detection has significant market opportunities globally.


Mirxes Holding (2629 HK) Placement: Operating in Niche Segment With Significant Growth Opportunity